Glimepiride Tablet
Product Images NDC 43063-587

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Glimepiride (NDC 43063-587). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

43063587 Label (43063587)

Label for Glimepiride USP 4 mg tablets by PD-Rx Pharmaceuticals, Inc. The label indicates a package size of 30 tablets with prescription-only status. It includes an NDC number 43063-587-30, reorder number 110171, lot number H19C81, and an expiration date of 03/2020. Safety warnings and dosage instructions placeholders are present, along with barcodes and a QR code.*

FDA Label Image

Structure (Glimepiride Structure)

Chemical structure diagram of glimepiride, showing its molecular composition and bonding arrangement as a sulfonylurea compound used in oral diabetes treatment.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.